Senores Pharmaceuticals IPO Subscription Status
Senores Pharmaceuticals IPO was subscribed 96.96 times when bidding closed on 24 Dec 2024: QIB 97.84x, NII 100.35x, Retail 93.16x.
The Senores Pharmaceuticals IPO has been subscribed 96.96x times overall. Retail investors have shown interest with bids for 93.16x the shares available. The Non-Institutional Investor (NII) category has been subscribed 100.35x. Within NII, Big HNI (B-HNI) subscribed 97.66x and Small HNI (S-HNI) subscribed 105.73x. Qualified Institutional Buyers (QIBs) have subscribed 97.84x. Data last updated on 10 Nov, 11:39 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 20 Dec, 2024 and closes on 24 Dec, 2024. The shares are expected to list on stock exchanges on 30 Dec, 2024.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of - - | 97.84x |
| NII | - of - - | 100.35x |
bHNI — bid amount above ₹10 Lakh |
- - | 97.66 |
sHNI — bid amount ₹2–10 Lakh |
- - | 105.73 |
| Retail | - of - - | 93.16x |
| TOTAL | - - | 96.96x |
Senores Pharmaceuticals IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 94 applicants will be successful.
Market Sentiment
Strong grey market premium of 69% suggests exceptional listing gains and high bullish sentiment among traders.
Institutional Backing
Massive institutional interest with QIBs subscribing 97.84x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
24 Dec 2024
Day 3 |
96.96x | ▼ | |
|
QIB97.84x
BHNI97.66x
SHNI105.73x
Retail93.16x
|
|||
|
23 Dec 2024
Day 2 |
13.87x | ▼ | |
|
QIB0.35x
BHNI20.14x
SHNI33.15x
Retail38.32x
|
|||
|
20 Dec 2024
Day 1 |
1.78x | ▼ | |
|
QIB0.01x
BHNI1.11x
SHNI2.8x
Retail7.2x
|
|||
Senores Pharmaceuticals IPO dates
From the bidding window to listing. Today is 11 November.
- Open 20 Dec 2024
- Close 24 Dec 2024
- Allotment 26 Dec 2024
- Refund/credit 27 Dec 2024
- Listing 30 Dec 2024
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Senores Pharmaceuticals IPO?
As of IPO close date (24 Dec, 2024), the Senores Pharmaceuticals IPO is subscribed 96.96x times. Retail category is 93.16x, and NII is 100.35x subscribed.
When is the allotment date for Senores Pharmaceuticals IPO?
The allotment for Senores Pharmaceuticals IPO is expected to be finalized on 26 December, 2024.
What is the GMP of Senores Pharmaceuticals?
The Grey Market Premium (GMP) for Senores Pharmaceuticals is currently ₹270, indicating a potential listing gain of 69%.
When will Senores Pharmaceuticals IPO list on the stock market?
Senores Pharmaceuticals is scheduled to list on BSE and NSE on 30 December, 2024.
What are the chances of getting allotment in Senores Pharmaceuticals IPO?
The retail category is oversubscribed at 93.16x, meaning allotment is by lottery. Statistically, approximately 1 in 94 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 97.84x mean for Senores Pharmaceuticals IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 97.84x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Senores Pharmaceuticals IPO allotment status?
After the allotment date (26 Dec, 2024), you can check your Senores Pharmaceuticals IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Senores Pharmaceuticals IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
